Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| AgBiome | 2021 | Series D | $116.0M | Raleigh |
| Altos Labs | 2021 | Series A | $3.0B | San Francisco |
| ImmuneID | 2021 | Series A | $50.0M | Boston |
| LunaPBC | 2021 | Series Unknown | $3.8M | San Diego |
| Brii Biosciences | 2021 | Series C | $155.0M | Beijing |
| Voxel8 | 2021 | Debt Financing | Undisclosed | Somerville |
| Encoded Therapeutics | 2021 | Series D | Undisclosed | South San Francisco |
| Vividion Therapeutics | 2021 | Series C | $135.0M | San Diego |
| Locanabio | 2020 | Series B | $100.0M | San Diego |
| SAGE Therapeutics | 2020 | Post Ipo Equity | $650.0M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | AgBiome | Series D | $116.0M | Raleigh, United States |
| 127 | Altos Labs | Series A | $3.0B | San Francisco, United States |
| 128 | ImmuneID | Series A | $50.0M | Boston, United States |
| 129 | LunaPBC | Series Unknown | $3.8M | San Diego, United States |
| 130 | Brii Biosciences | Series C | $155.0M | Beijing, China |
| 131 | Voxel8 | Debt Financing | Undisclosed | Somerville, United States |
| 132 | Encoded Therapeutics | Series D | Undisclosed | South San Francisco, United States |
| 133 | Vividion Therapeutics | Series C | $135.0M | San Diego, United States |
| 134 | Locanabio | Series B | $100.0M | San Diego, United States |
| 135 | SAGE Therapeutics | Post Ipo Equity | $650.0M | Cambridge, United States |
AgBiome discovers and develops innovative biological and trait products for crop protection.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
ImmuneID is a precision immunology company that provides a technological platform to deliver insights into the human immune response.
LunaPBC is a healthcare company that transforms health data into health breakthroughs.
Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.
Voxel8 offers digital manufacturing technology designed for footwear and apparel.
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Biopalette operates a platform designed to provide gene-editing techniques.
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
One BioMed is a medical diagnostics company.
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.
Genuity Science is a biotechnology company that offers clinco-omics data analysis solutions for researchers.
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
Nebula Genomics leverages blockchain technology to eliminate middlemen and empower people to own their personal genomic data.
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics.
Clinical development and commercialization of innovative aesthetics and medical dermatology products based on scientific breakthroughs
Nohla Therapeutics is a biotechnology company that develops a shelf alternative to bone marrow transplants.
Hua Medicine is a clinical-stage, innovative drug development company in China.
ARCH Venture Partners has invested in 156 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 29 different industry categories.
Among tracked funding rounds, Altos Labs received $3.0B in a Series A round. ARCH Venture Partners's total known invested capital is $14.3B.
ARCH Venture Partners's average investment size is $119.8M across its portfolio of 156 companies.
Recent ARCH Venture Partners portfolio additions include AgBiome, Altos Labs, ImmuneID, LunaPBC, Brii Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors